Logos Global Master Fund Lp - Net Worth and Insider Trading
Logos Global Master Fund Lp Net Worth
The estimated net worth of Logos Global Master Fund Lp is at least $7 Million dollars as of 2025-05-25. Logos Global Master Fund Lp is the 10% Owner of Viridian Therapeutics Inc and owns about 550,000 shares of Viridian Therapeutics Inc (VRDN) stock worth over $7 Million. Details can be seen in Logos Global Master Fund Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Logos Global Master Fund Lp has not made any transactions after 2020-11-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Logos Global Master Fund Lp
Logos Global Master Fund Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Logos Global Master Fund Lp owns 1 companies in total, including Viridian Therapeutics Inc (VRDN) .
Click here to see the complete history of Logos Global Master Fund Lp’s form 4 insider trades.
Insider Ownership Summary of Logos Global Master Fund Lp
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| VRDN | Viridian Therapeutics Inc | 2020-11-13 | 10 percent owner |
Logos Global Master Fund Lp Latest Holdings Summary
Logos Global Master Fund Lp currently owns a total of 1 stock. Logos Global Master Fund Lp owns 550,000 shares of Viridian Therapeutics Inc (VRDN) as of November 13, 2020, with a value of $7 Million.
Latest Holdings of Logos Global Master Fund Lp
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics Inc | 2020-11-13 | 550,000 | 13.57 | 7,463,500 |
Holding Weightings of Logos Global Master Fund Lp
Logos Global Master Fund Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Logos Global Master Fund Lp has made a total of 1 transactions in Viridian Therapeutics Inc (VRDN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Viridian Therapeutics Inc is the acquisition of 476,667 shares on November 13, 2020, which cost Logos Global Master Fund Lp around $2 Million.
Insider Trading History of Logos Global Master Fund Lp
- 1
Logos Global Master Fund Lp Trading Performance
GuruFocus tracks the stock performance after each of Logos Global Master Fund Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Logos Global Master Fund Lp is 20.34%. GuruFocus also compares Logos Global Master Fund Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Logos Global Master Fund Lp within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Logos Global Master Fund Lp's insider trading performs compared to the benchmark.
Performance of Logos Global Master Fund Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.03 | | | | | |
| Relative Return to S&P 500(%) | 13.85 | | | | | |
Logos Global Master Fund Lp Ownership Network
Ownership Network List of Logos Global Master Fund Lp
Ownership Network Relation of Logos Global Master Fund Lp
Logos Global Master Fund Lp Owned Company Details
What does Viridian Therapeutics Inc do?
Who are the key executives at Viridian Therapeutics Inc?
Logos Global Master Fund Lp is the 10 percent owner of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & President and CEO Stephen F. Mahoney , Chief Operating Officer Thomas W. Beetham , and director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc .
Viridian Therapeutics Inc (VRDN) Insider Trades Summary
Over the past 18 months, Logos Global Master Fund Lp made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc , and a net purchase of 21,400 shares made by Stephen F. Mahoney .
In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,102,590 shares.
Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viridian Therapeutics Inc Insider Transactions
Logos Global Master Fund Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Logos Global Master Fund Lp. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Logos Global Master Fund Lp's mailing address is: Camana Bay E9 Ky1-9009.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
